Bal Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bal Pharma Ltd. on BSE

Load latest

Bal Pharma Ltd.

16 Nov 2022

85.33

0.06%

Company Update

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are submitting the news paper publications of unaudited financial results of the Company for the quarter ended 30.09.2022.

pdf

Bal Pharma Ltd.

14 Nov 2022

85.33

0.06%

Result

BAL PHARMA LTD. - 524824 - Unaudited Financial Results For The Quarter And Half Year Ended …

BSE India

Board of Directors of the Company has met today and inter alia transacted the following business. 1.Taken on record and approved the Unaudited financial results of the Company for the quarter and half year ended 30.09.2022. A copy of the standalone and consolidated financial results together with the balance sheets, cash flow statements and limited review reports issued by the statutory auditors of the Company with un modified opinion is enclosed . 2.Convened Extra Ordinary meeting of the shareholders of the Company on 14th December 2022 to take their approval for filing application with NCLT for the merger of Golden Drugs Pvt Ltd, a wholly owned subsidiary of the Company. 3.Approved the allotment of 1,17,500 equity shares to the employees of the Company who has exercised the stock options vested on them, under Bal Pharma Ltd employee stock option plan 2014. The Board meeting commenced at 5.30 p.m and concluded at 6.20 p.m on 14.11.2022.

pdf

Bal Pharma Ltd.

14 Nov 2022

85.33

0.06%

Board Meeting

BAL PHARMA LTD. - 524824 - Board Meeting Outcome for Outcome Of The Board Meeting-Unaudited Financial …

BSE India

pdf

Bal Pharma Ltd.

04 Nov 2022

85.33

0.06%

Board Meeting

BAL PHARMA LTD. - 524824 - Board Meeting Intimation for Un-Audited Standalone And Consolidated Financial Results …

BSE India

BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve 1.Un-audited standalone and consolidated financial results for the quarter & half year ended 30.09.2022. 2.To allot equity shares to the eligible employees, upon exercise of ESOP''s. 3. To convene Extra Ordinary General Meeting ( EGM ) for merger of Golden Drugs Pvt Ltd , a wholly owned subsidiary of the Company.

pdf

Bal Pharma Ltd.

21 Oct 2022

85.33

0.06%

Corp. Note

BAL PHARMA LTD. - 524824 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

We are submitting to the exchange intimation received from our R&T agents i.e TSR Darashaw Ltd, Mumbai, regarding loss of share certificates by one of our shareholder.

pdf

Bal Pharma Ltd.

03 Oct 2022

85.33

0.06%

Company Update

BAL PHARMA LTD. - 524824 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Based on the certificate's received from our R&T agents i.e TSR Darashaw Pvt Ltd, we would like to confirm that the details of securities dematerialized / rematerialized during the quarter ended on 30.09.2022 have been furnished to all the stock exchanges where the equity shares of the Company are listed, within the prescribed time limit. The Share certificates received for dematerialization, if any has been mutilated and cancelled after due verification and the name of the depository has been substituted in the records as registered owner, within 15 days of the receipt of the certificate of security.

pdf

Bal Pharma Ltd.

03 Oct 2022

85.33

0.06%

SAST

BAL PHARMA LTD. - 524824 - Closure of Trading Window

BSE India

Pursuant to the Code of conduct of the Company and as per the amended provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform the exchange that the trading window for dealing with the securities of the Company on the designated employees and their relatives will be closed from 1st October 2022 and up to 48 hours of the declaration of the unaudited financial results of the Company, for the quarter ended 30/09/2022. The date of the Board meeting for declaration of the unaudited financial results, will be intimated to the exchange in due course.

pdf

Bal Pharma Ltd.

28 Sep 2022

85.33

0.06%

Corp. Note

BAL PHARMA LTD. - 524824 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation regarding loss of share certificate.

pdf

Bal Pharma Ltd.

23 Sep 2022, 04:22PM

85.33

0.06%

Company Update

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of …

BSE India

We would like to inform the exchanges that the shareholders of the Company at their meeting held on 19.09.2022 has approved the adoption of new set of Memorandum of Association & Articles of Association of the Company, as per the provisions of the Companies Act,2013, through a special resolution. We are submitting to the exchange copy of the revised MOA&AOA of the Company, for your records.

pdf

Bal Pharma Ltd.

23 Sep 2022

85.33

0.06%

Investor Presentation

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Audio Visual recording of the webinar can we assessed through the following weblink https://www.balpharma.com/ip

pdf

Is Bal Pharma Ltd. worth buying?

53 Votes:

Buy 75.47%

Sell 13.21%

Hold 11.32%